arsenic has been researched along with Cancer of Liver in 197 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (18.78) | 18.7374 |
| 1990's | 10 (5.08) | 18.2507 |
| 2000's | 55 (27.92) | 29.6817 |
| 2010's | 80 (40.61) | 24.3611 |
| 2020's | 15 (7.61) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Bhardwaj, SK; Chaudhary, A; Haque, R; Khan, A; Sinha, KK; Srivastava, A | 1 |
| Cheng, M; Li, B; Li, F; Piao, JG; Sun, J; Wei, Y; Ye, T; Zheng, H; Zhou, M | 1 |
| Aki, T; Funakoshi, T; Kukita, M; Takata, M; Uemura, K; Unuma, K | 1 |
| Dongbin, X; Hulai, W; Jing, S; Jingke, Z; Xiaoxia, X; Yanying, Z; Yonggang, T | 1 |
| Gu, SY; Li, Y; Zhang, ZZ | 1 |
| Doi, K; Fujioka, M; Gi, M; Kakehashi, A; Okuno, T; Wanibuchi, H; Yamaguchi, T | 1 |
| Fang, L; Huang, P; Islam, K; Liu, YJ; Naranmandura, H; Wang, C; Yang, C; Zhang, H; Zhang, YH; Zhang, YW; Zheng, XW | 1 |
| Du, P; Lu, W; Yang, C; Zhang, JC; Zhang, JL | 1 |
| Fu, Y; Guo, BB; Jiang, HY; Li, S; Liu, LY; Wang, KK; Wu, CJ; Zhang, CM; Zhang, F; Zhang, Y | 1 |
| Chen, CF; Chern, CL; Ho, CT; Lin, LC; Liu, JJ; Liu, TZ | 1 |
| Hai, Y; Li, H; Li, Y; Ma, W; Song, P; Wang, X; Wu, Z; Xie, Q; Zhao, L | 1 |
| Ali, M; Ali, V; Bimal, S; Haque, R; Kumar, N; Sadaf, N | 1 |
| Ji, S; Li, W; Wang, L; Wang, M; Zhang, C; Zhang, J | 1 |
| Fujioka, M; Kakehashi, A; Kato, M; Kitano, M; Tago, Y; Wanibuchi, H; Wei, M; Yamada, T; Yamano, S | 1 |
| Ao, JY; Bu, Y; Chai, ZT; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Zhang, KZ; Zhang, QB; Zhang, YY; Zhu, XD | 1 |
| Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X | 1 |
| Fang, ZT; Li, S; Liu, R; Qian, S; Qu, XD; Wang, GZ; Wang, JH; Wang, LL; Yang, GW; Yang, MJ; Zhang, W; Zhang, WS; Zhu, L | 1 |
| Fan, Z; Huaqun, F; Kai, W; Kaiyang, W; Linquan, W; Mingwen, H; Xiangbao, Y; Xin, Y | 1 |
| Chen, X; Jiang, H; Li, Y; Liang, Y; Liu, J; Liu, L; Lu, Z; Meng, X; Pan, S; Qi, S; Song, X; Sun, B; Wang, J; Xie, C; Yin, D; Zheng, T | 1 |
| Akrami, SM; Habibi, L; Karimi, A; Madjd, Z | 1 |
| Fu, HQ; Huang, MW; Wang, K; Wang, KY; Wu, LQ; Yin, XB; Yu, X; Zhou, F | 1 |
| Liu, F; Wang, W; Wei, J; Ye, C | 1 |
| Jiang, F; Li, Y; Li, Z; Liu, Q; Shen, J; Wang, X; Zhang, J | 1 |
| Jiang, F; Li, Y; Li, Z; Liu, Q; Lu, X; Shen, J; Wang, X; Zhang, J | 1 |
| Chen, CZ; Hu, YN; Jiang, XJ; Zhang, ZZ; Zhao, W | 1 |
| He, C; Jiang, H; Jiang, X; Ma, L; Sun, X; Xu, L; Zhai, B; Zhao, D | 1 |
| Ling, S; Sun, D; Tian, Y; Wang, L; Yang, X | 1 |
| Deng, J; Li, Y; Luo, Q; Zhang, Z | 1 |
| He, X; Hu, BS; Huang, JW; Li, Y; Liu, B; Lu, LG; Zhao, W; Zheng, YB | 1 |
| Deng, JJ; Li, Y; Luo, QY; Zhang, ZZ | 1 |
| Lai, Y; Li, Y; Luo, Q; Zhang, Z | 1 |
| Jin, G; Liu, D; Liu, Y; Sun, Z; Wang, C; Wang, H; Wang, X; Yu, S; Zhang, B | 1 |
| Gao, B; Lu, M; Meng, X; Miao, Z; Qiao, X; Wu, L; Xue, D; Zhang, W | 1 |
| Cao, Y; Fan, J; He, YF; Hu, B; Huang, XW; Qiu, SJ; Sun, C; Sun, YF; Wang, Z; Yang, XR; Zeng, HY; Zhang, X; Zhou, J | 1 |
| Nohara, K; Suzuki, T | 1 |
| Cao, Z; Chen, X; Cui, L; Gao, B; Zhang, S; Zhang, W | 1 |
| Chi, X; Gao, J; Liu, H; Shan, H; Zhang, Z; Zhao, Z; Zhou, H; Zhu, X | 1 |
| Chen, C; Hu, H; Li, H | 1 |
| Chen, FY; Gu, ZJ; Kulkarni, P; Li, JQ; Li, L; Liu, L; Mason, RP; Tang, BB; Tang, Q; Yi, JW | 1 |
| Gu, SY; Hu, YN; Zhang, ZZ | 1 |
| Chen, M; Cheng, X; Fan, X; Ji, J; Song, J; Wu, F; Ying, X; Zhang, D; Zhao, Z | 1 |
| Chang, Y; Jiang, M; Zhou, Q; Zhou, R; Zhu, C | 1 |
| Fan, L; Liang, K; Liang, W; Peng, G; Wang, L; Wang, R; Xu, Y; Ye, Q | 1 |
| Chen, P; Cui, P; Duan, Z; Gao, Q; Li, H; Li, Y; Song, P; Wang, A; Wang, D; Wang, X; Wang, Y; Wu, Z; Zhao, L; Zhu, R; Zhu, S | 1 |
| Fei, W; Han, S; Li, F; Tao, J; Wang, X; Wei, Y; Zhang, Y; Zheng, H; Zhu, J | 1 |
| Gao, F; Liu, Y; Song, W | 1 |
| Lou, Z; Shen, L; Xu, G; Zhang, G | 1 |
| Lv, XH; Wang, CH; Xie, Y | 1 |
| Cheng, C; Cui, X; Fei, M; Gao, S; He, S; Ke, Q; Li, P; Liu, Y; Lu, M; Shen, A; Wang, Y; Zhao, Y | 1 |
| Aklilu, M; Kindler, HL; Nattam, S; Vokes, EE | 1 |
| Cao, EH; Liang, XQ; Liu, XM; Song, Y; Tang, RJ; Xiong, XF | 1 |
| Kita, K; Ochi, T; Sato, M; Suzuki, T | 1 |
| Chen, X; Liu, LX; Zhang, M | 1 |
| Song, J; Wang, ZY; Zhang, DS | 1 |
| Abbadessa, G; Blaszkowsky, LS; Chen, H; Costa, M; Feun, L; Gold, P; Henderson, C; Hochster, H; Lewis, J; Muggia, F; Nierodzik, M; Rosenzweig, B; Ryan, T; Van Veldhuizen, P; Wu, J; Zheng, H; Zhu, AX | 1 |
| Jiang, HC; Liu, TF; Song, PL; Sun, B; Zhao, XS | 1 |
| Chen, X; Jiang, H; Krissansen, GW; Ma, Y; Pan, S; Sun, B; Sun, X | 1 |
| Chen, X; Jiang, H; Liu, L; Ma, Y; Pan, S; Sun, X; Wang, J; Zhu, H | 1 |
| Chen, X; Jiang, HC; Liu, LX; Meng, XZ; Pan, SH; Wang, JB; Zhang, WH; Zheng, TS | 1 |
| Chang, YJ; Cheng, YW; Chiou, JF; Hsieh, PY; Hsu, CH; Ko, HL; Liu, TZ; Ting, LL; Tung, JN; Wu, AT | 1 |
| Han, H; Jiang, T; Lu, H; Luo, R; Shen, P | 1 |
| Chen, BA; Liu, L; Qin, SK | 1 |
| Gu, N; Li, GZ; Lu, Q; Niu, HZ; Teng, GJ; Wang, ZY; Xu, RZ; Yu, H; Zhang, DS; Zhu, GY | 1 |
| Chen, C; Huang, D; Qi, Y; Wang, Y; Xi, Y; Zhang, Y | 1 |
| Hua, H; Li, J; Qin, S; Rui, J | 1 |
| Hong, DY; Huang, HS; Liu, ZM; Tseng, JT | 1 |
| Acalovschi, M; Aldea, M; Fischer-Fodor, E; Irimie, A; Kacso, G; Mosteanu, O; Petrushev, B; Pop, T; Soritau, O; Susman, S; Tomuleasa, C | 1 |
| Bian, J; Guo, J; Wang, Y; Wu, H; Wu, X; Zhang, C; Zhang, S; Zhou, J | 1 |
| Chen, G; Chen, JX; Hua, ZC; Tang, B; Wang, K; Yang, BY | 1 |
| Dumitrescu, LS; Fischer-Fodor, E; Hey-Hawkins, E; Lönnecke, P; Mikláš, R; Miklášová, N; Schrepler, MP; Tomuleasa, CI; Virag, P | 1 |
| Chen, Q; Hao, XZ; Liu, JW; Qin, SK; Qu, FL; Qu, T; Sui, GJ; Sun, Y; Zhang, HP | 1 |
| Diwan, BA; Thomas, DJ; Tokar, EJ; Waalkes, MP | 1 |
| Jia, S; Yang, S; Yang, T; Yang, Y; Zhang, X | 1 |
| Allensworth, JL; Devi, GR; Diehl, AM; Lyerly, HK; Morse, MA; Rangwala, F; Smith, GR; Thomas, Z; Williams, KP | 1 |
| Cao, LM; Li, HY | 1 |
| Cheng, HT; Guo, CY; Hu, HT; Li, HL; Luo, JP; Meng, YL; Xiao, JC; Yao, QJ | 1 |
| Chen, CX; Huang, FL; Wang, HN; Wang, YL | 1 |
| Allain, N; Fardel, O; Guillouzo, A; Le Vée, M; Morel, F; Vernhet, L | 1 |
| Liu, JW; Shen, Y; Tang, Y; Zhong, XY | 1 |
| Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L | 1 |
| Hong, L; Qi, QH; Wang, SS; Wang, XL; Zhang, T | 1 |
| Wang, ZH; Yu, D; Zhu, LY | 1 |
| JHAVERI, SS | 1 |
| Akao, Y; Futatsugawa, S; Kito, M; Matsumoto, K; Naoe, T; Nozawa, Y; Sera, K; Wada, N | 1 |
| Dorsey, WC; Tchounwou, PB; Yedjou, CG | 1 |
| Li, JT; Ou, QJ; Wu, YC | 1 |
| Ahmed, M; Gazelle, GS; Goldberg, SN; Horkan, C; Kruskal, JB; Liu, Z; Solazzo, SA | 1 |
| Chen, H; Hua, HQ; Qin, SK; Wang, JH | 1 |
| Chen, W; Guo, HX; Jiang, HC; Liu, LX; Liu, ZH; Wang, XQ; Wu, M; Zhang, TD; Zhu, AL | 1 |
| Dong, X; Jiang, H; Kanwar, JR; Krissansen, GW; Luo, L; Meng, F; Qiao, H; Sun, X; Zhou, B | 1 |
| Cui, X; Hatakeyama, K; Hirano, S; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Fu, Q; Hu, BR; Li, JJ; Li, Y; Ming, ZY; Qian, JQ; Tang, Q; Xiang, JZ | 1 |
| Cheng, AL; Hsu, C; Hsu, CH; Hsu, WL; Lin, CC; Yang, CH | 1 |
| Kumar, R; Mukhopadhyay, AK; Paul, MK | 1 |
| Cui, XP; Li, P; Lu, MD; Shen, AG; Wang, Y | 1 |
| Chen, Q; Gao, P; Jin, H; Tian, C; Wang, X; Yue, W; Zheng, Y | 1 |
| Cui, YZ; Luo, RC; Wu, J; Zhang, H | 1 |
| Calmus, Y; Poupon, R | 1 |
| Mendelow, H; Pataki, KI; Roat, JW; Wald, A | 1 |
| Eichner, D; Gottschalk, D; Gottschalk, I; Norpoth, K; Schmidt, EH; Thomas, H; Witting, U | 1 |
| Bruguera, M; Castells, A; Forns, X; Navasa, M; Rodés, J; Salgado, M; Sans, M | 1 |
| Gottesman, MM; Pastan, I; Shen, D | 1 |
| Busteros, JI; Dueñas, C; López-Morante, A; Martin-Lorente, JL; Pérez-Alvarez, JC; Sáez-Royuela, F; Yuguero, L | 1 |
| Chen, H; Liu, L; Liu, W; Ma, J; Qin, S; Wang, J | 1 |
| Ishaque, AB; Schneider, J; Tchounwou, PB; Wilson, BA | 1 |
| Chen, Y; He, Z; Liu, X; Qian, J; Qin, S; Shao, Z; Wang, L | 1 |
| He, Z; Qian, J; Qin, S | 1 |
| Akao, Y; Kito, M; Nozawa, Y; Ohishi, N; Yagi, K | 1 |
| Chan, JY; Fung, KP; Siu, KP | 1 |
| Chabner, BA; Doroshow, JH; Locker, GY; Zwelling, LA | 1 |
| Berk, PD; Creech, J; Falk, H; Martin, JF; Popper, H; Selikoff, IJ; Thomas, L; Watanabe, P; Young, RS | 1 |
| Nyfors, A; Sogaard, H; Zachariae, H | 1 |
| Grinnell, F; Shere, PA | 1 |
| Galt, RM; Knock, FE; Oester, YT; Sylvester, R | 1 |
| Khan, H; Rana, SVS; Verma, Y | 1 |
| Chen, H; Chen, J; Chen, X; Chen, Z; Huang, Y; Li, D; Su, Z; Wang, H | 1 |
| Deng, M; Gao, M; Guo, G; Han, J; Huang, H; Huang, J; Huang, X; Jing, J; Kloeber, JA; Liu, S; Lou, Z; Qi, Z; Xu, M; Xu, Z | 1 |
| Acharya, PB; Kuppusamy Selvam, M; Mukherjee, A; Singh, A | 1 |
| Nohara, K; Okamura, K; Sato, M; Suzuki, T | 1 |
| Chen, J; Gu, J; Guo, J; Hu, X; Li, D; Li, X; Liu, J; Mei, C; Peng, C; Xiao, Y; Zhang, K; Zhang, X; Zhou, B | 1 |
| Cao, H; Liu, Q; Sun, J; Wu, L; Wu, M | 1 |
| Fischer, F; Gunesch, S; Hartwig, A; Lumpp, T; Schumacher, P; Stößer, S | 1 |
| El-Serag, HB; Olayode, A; Oluyomi, AO; Roy, H; Symanski, E; Thrift, AP | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Cui, H; Deng, H; Deng, J; Deng, Y; Hu, Y; Ren, Z; Tang, W; Wu, Q; Xu, SY; Yu, S; Zuo, Z | 1 |
| Jin, Z; Wu, P; Yan, G; Yang, J; Yi, X; Zhou, M | 1 |
| Jiang, W; Liu, S; Nurmamat, H; Shen, Z; Wu, B; Wu, J; Yu, Y | 1 |
| Nohara, K; Okamura, K; Suzuki, T; Takumi, S | 1 |
| Cheng, S; Wang, W; Zhang, D | 1 |
| Biondi, A; Costa, C; Costanzo, V; Fago, L; Fenga, C; Ferrante, M; Fuccio Sanzà, G; Ledda, C; Loreto, C; Marconi, A; Matera, S; Palmucci, S; Pomara, C; Rapisarda, V; Zammit, C | 1 |
| Choiniere, J; Wang, L; Wu, J | 1 |
| Liu, J; Waalkes, MP | 1 |
| Ferreccio, C; Liaw, J; Marshall, G; Smith, AH; Steinmaus, C; Yuan, Y | 1 |
| Bortner, C; Liu, J; Sifre, MI; Sun, Y; Tokar, EJ; Waalkes, MP; Yu, L | 1 |
| Lai, R; Li, X; Wang, Y; Yu, RA | 1 |
| Kim, EY; Kim, HJ; Kim, TH; Park, CS; Park, YS; Shin, JH; Song, HY | 1 |
| Hirano, S; Kobayashi, Y; Mizumura, A; Watanabe, T | 1 |
| Afridi, HI; Baig, JA; Chandio, AA; Kandhro, GA; Kazi, TG; Khan, S; Kolachi, NF; Nasreen, S; Shah, AQ; Wadhwa, SK | 1 |
| Callegari, E; Elamin, BK; Gramantieri, L; Negrini, M; Sabbioni, S | 1 |
| Chang, HT; Guo, HR; Huang, NC; Lin, SL; Wang, JS; Wann, SR | 1 |
| Diwan, BA; Tokar, EJ; Waalkes, MP | 1 |
| Chen, CY; Guo, HR; Hung, TL; Sung, TI; Wang, YJ | 1 |
| Afridi, HI; Kazi, NG; Kazi, TG; Khan, S; Kolachi, NF | 1 |
| Afridi, HI; Arain, SS; Kazi, NG; Kazi, TG; Kolachi, NF | 1 |
| Chen, CY; Guo, HR; Lin, HJ; Sung, TI | 1 |
| Centeno, JA; Gibb, H; Ladich, ER; Longfellow, D; Martinez, L; Mullick, FG; Page, NP; Thompson, C | 1 |
| ROTH, F | 1 |
| Diwan, BA; Liu, J; Waalkes, MP; Ward, JM; Xie, Y | 1 |
| Ahsan, H; Chen, Y | 1 |
| Chiu, HF; Ho, SC; Wang, LY; Wu, TN; Yang, CY | 1 |
| Yu, MC; Yuan, JM | 1 |
| Kim, SG; Lee, CH; Park, JW | 1 |
| Li, L; Liu, Z; Shi, H; Sun, H; Wu, W | 1 |
| Collins, J; Diwan, BA; Ducharme, DM; Liu, J; Logsdon, D; Merrick, BA; Shen, J; Waalkes, MP; Xie, Y | 1 |
| Diwan, BA; Ducharme, DM; Grissom, SF; Liu, J; Merrick, BA; Paules, RS; Shen, J; Tennant, R; Tucker, CJ; Waalkes, MP; Xie, Y | 1 |
| Diwan, BA; Liu, J; Waalkes, MP; Ward, JM | 1 |
| Atmaca, M; Fry, JR; Gottschalg, E; Kind, CN; Moore, NE; Pratt, S; Ryan, AK; Travis, LC; Waller, RC | 1 |
| Benbrahim-Tallaa, L; Boos, J; Liu, J; Qian, X; Qu, W; Waalkes, MP; Xie, Y; Yu, L | 1 |
| Begum, RA; Farah, IO; Ishaque, AB | 1 |
| Arnold, W; Bleese, N | 1 |
| Kasper, ML; Schoenfield, L; Strom, RL; Theologides, A | 1 |
| Rakovic, M | 1 |
| Balázs, L; Barna, K; Kádas, I; Pár, A | 2 |
| Lüchtrath, H | 1 |
| Caldwell, GG; Falk, H; Ishak, KG; Popper, H; Thomas, LB | 1 |
| Brady, JA; Cardamone, AT; Vianna, NJ | 1 |
| Edmonds, L; Falk, H; Heath, CW; Herbert, JT; Popper, H; Thomas, LB | 1 |
| Vianna, NJ | 1 |
| Ghai, GL; Prunés, L; Zaldívar, R | 1 |
| Brown, KG; Chen, CJ | 1 |
| Luo, FJ; Luo, ZD; Ma, L | 1 |
| Biggs, ML; Hopenhayn-Rich, C; Smith, AH | 1 |
| Chen, CJ; Kuo, TL; Morales, KH; Ryan, L; Wu, MM | 1 |
| Cheng, ML; LeCluyse, EL; Liu, J; Lu, T; Waalkes, MP; Zhou, YS | 1 |
| Alpert, M | 1 |
| Aposhian, HV; Chen, ML; Liu, J; Waalkes, MP; Zhang, A; Zheng, B; Zhou, Y | 1 |
| Popper, H | 1 |
| Cowen, AE; Cowlishaw, JL; Pollard, EJ; Powell, LW | 1 |
| Malchow, H; Schmeisser, W | 1 |
| Gerber, MA; Popper, H; Schaffner, F; Selikoff, IJ | 1 |
| Falk, H; Popper, H; Selikoff, IJ; Telles, NC; Thomas, LB | 1 |
| Alrenga, DP | 1 |
| Aach, RD; Boswell, DC; Lander, JJ; Stanley, RJ; Sumner, HW | 1 |
| Bates, MN; Duggan, HM; Goeden, HM; Hertz-Picciotto, I; Hopenhayn-Rich, C; Kosnett, MJ; Smith, AH; Smith, MT; Wood, R | 1 |
| Chen, CJ; Chen, CW; Kuo, TL; Wu, MM | 1 |
| Fujita, H; Kappas, A; Mitani, K; Sassa, S | 1 |
| De Groote, J; Desmet, V; Fevery, J; Nevens, F; Sciot, R; Van Steenbergen, W | 1 |
| Antoniello, L; Cohen, H; Fosman, E; Rodríguez, J; Rondán, M | 1 |
| Philipp, R | 1 |
| Nigam, VN | 1 |
| Arcos, JC; Mathison, JB; Mouledoux, AM; Tison, MJ | 1 |
| Grinnell, F; Milam, M; Srere, PA | 1 |
| Carmack, C; Geokas, MC; Haverback, BJ; Rinderknecht, H | 1 |
| Holland, JF; Kim, U; Ospina, J; Regelson, W | 1 |
| Kanisawa, M; Schroeder, HA | 1 |
24 review(s) available for arsenic and Cancer of Liver
| Article | Year |
|---|---|
Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Oxides | 2022 |
Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Oxides; Quality of Life; Survival Rate; Treatment Outcome | 2018 |
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
Topics: Animals; Arsenicals; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression; Histone Code; Humans; Liver Neoplasms; Maternal Exposure; Maternal-Fetal Exchange; Mice, Inbred C3H; Pregnancy; Proto-Oncogene Proteins c-fos | 2015 |
Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Databases, Bibliographic; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2017 |
[The liver and arsenic].
Topics: Animals; Arsenic; Arsenic Poisoning; Arsenicals; Chemical and Drug Induced Liver Injury; Hemangiosarcoma; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms | 1982 |
[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature].
Topics: Arsenicals; Arsphenamine; Biopsy; Fatal Outcome; Hemangiosarcoma; Hemoperitoneum; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Shock; Syphilis; Time Factors | 1995 |
Idiopathic portal hypertension and angiosarcoma associated with arsenical salts therapy.
Topics: Arsenicals; Hemangiosarcoma; Humans; Hypertension, Portal; Liver Neoplasms; Male; Middle Aged; Psoriasis | 1998 |
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.
Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Doxorubicin; Female; Hemangiosarcoma; Hemochromatosis; Hepatectomy; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prognosis; Radium; Thorium Dioxide; Vinyl Chloride | 1979 |
Non-coding RNA therapeutics: Towards a new candidate for arsenic-induced liver disease.
Topics: Arsenic; Biomarkers; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; MicroRNAs; RNA, Long Noncoding; RNA, Untranslated | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Increase in incidence of hepatic tumors caused by oncogenic somatic mutation in mice maternally exposed to inorganic arsenic and the multigenerational and transgenerational effects of inorganic arsenic.
Topics: Animals; Arsenic; DNA Methylation; Epigenesis, Genetic; Female; Humans; Liver Neoplasms; Maternal Exposure; Mice; Mutation | 2014 |
Association of inorganic arsenic exposure with liver cancer mortality: A meta-analysis.
Topics: Arsenic; China; Drinking Water; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Risk Factors; Water Pollutants, Chemical | 2014 |
Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
Topics: Arsenic; Cadmium; Carcinoma, Hepatocellular; Dioxins; Humans; Liver Neoplasms; Nitrosamines; Occupational Exposure; Pesticides; Polychlorinated Biphenyls; Risk Factors | 2017 |
Liver is a target of arsenic carcinogenesis.
Topics: Animals; Apoptosis; Arsenic; Carcinoma, Hepatocellular; DNA Damage; DNA Methylation; DNA Repair; Estrogens; Humans; Liver; Liver Neoplasms; Mice | 2008 |
MicroRNA response to environmental mutagens in liver.
Topics: Aflatoxin B1; Animals; Arsenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Environmental Pollutants; Ethanol; Gene Expression Regulation; Hepacivirus; Hepatitis B virus; Humans; Liver; Liver Neoplasms; MicroRNAs; Mutagens; Nicotiana; Poisons; Risk Factors; Rodenticides; Triazines | 2011 |
Arsenic, vinyl chloride, viral hepatitis, and hepatic angiosarcoma: a hospital-based study and review of literature in Taiwan.
Topics: Aged; Aged, 80 and over; Arsenic; Female; Hemangiosarcoma; Hepatitis C; Hospitals, Teaching; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Taiwan; Tomography, X-Ray Computed; Vinyl Chloride | 2011 |
Does arsenic exposure increase the risk for liver cancer?
Topics: Arsenic; Arsenic Poisoning; Carcinoma, Hepatocellular; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Risk; Sex Factors; Taiwan; Water Pollution, Chemical; Water Supply | 2004 |
Environmental factors and risk for hepatocellular carcinoma.
Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Diabetes Complications; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Obesity; Risk Factors; Smoking | 2004 |
Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China.
Topics: Adult; Aged; Arsenic; China; Coal; Environmental Exposure; Epidemiologic Studies; Female; Food Contamination; Humans; Incineration; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mining; Prevalence; Risk Assessment; Skin Diseases; Skin Neoplasms; Water Supply | 2002 |
[Occupational liver lesions].
Topics: Arsenic; Cadmium; Chemical and Drug Induced Liver Injury; Chromium; Fatty Liver; Humans; Liver Cirrhosis; Liver Neoplasms; Occupational Diseases; Paraquat; Time Factors; Vinyl Chloride | 1977 |
Environmental hepatic injury in man.
Topics: Adolescent; Adult; Aged; Animals; Arsenic; Carcinogens; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Environmental Pollutants; Female; Hemangiosarcoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Middle Aged; Necrosis; Pharmacology; Thorium Dioxide; Vinyl Chloride | 1979 |
Primary angiosarcoma of the liver. Review article.
Topics: Adolescent; Adult; Arsenic; Child; Child, Preschool; Chlorides; Female; Hemangiosarcoma; Humans; Infant; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Occupational Diseases; Prognosis; Thorium Dioxide; Vinyl Compounds | 1975 |
Cancer risks from arsenic in drinking water.
Topics: Animals; Arsenic; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Maximum Allowable Concentration; Mice; Neoplasms; Rats; Rats, Wistar; Taiwan; United States; United States Environmental Protection Agency; Urinary Bladder Neoplasms; Water Pollutants; Water Supply | 1992 |
Arsenic exposure: health effects and the risk of cancer.
Topics: Absorption; Arsenic; Arsenic Poisoning; Diet; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Leukemia; Liver Neoplasms; Mutagens; Neoplasms; Occupational Diseases; Respiratory Tract Neoplasms; Risk; Skin Neoplasms; Teratogens | 1985 |
11 trial(s) available for arsenic and Cancer of Liver
| Article | Year |
|---|---|
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytoskeletal Proteins; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides | 2017 |
Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Combined Modality Therapy; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Single-Blind Method; Treatment Outcome; Tumor Burden | 2015 |
Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Oxides; Proportional Hazards Models; Treatment Outcome | 2015 |
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Pancreatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Glutathione; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome | 2010 |
[Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Half-Life; Humans; Injections; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Oxides; Quality of Life; Remission Induction; Survival Rate; Vomiting | 2011 |
[The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases].
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Treatment Outcome | 2012 |
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Administration Schedule; Fatigue; Female; Humans; Injections, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxides; Survival Analysis; Treatment Outcome | 2007 |
[Arsenic trioxide for the treatment of medium and advanced primary liver cancer].
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; Remission Induction; Treatment Outcome; Vomiting | 2002 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Effects of mineral supplementation on liver cirrhotic/cancer male patients.
Topics: Adult; Arsenic; Cadmium; Dietary Supplements; Drinking Water; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Microwaves; Middle Aged; Minerals; Pakistan; Selenium; Spectrophotometry, Atomic; Zinc | 2012 |
163 other study(ies) available for arsenic and Cancer of Liver
| Article | Year |
|---|---|
Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
Topics: Antineoplastic Agents; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Oxides; Quercetin; Telomerase | 2023 |
Induction of filamin-C and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during arsenic trioxide exposure.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cellular Senescence; Filamins; Humans; Liver Neoplasms; Oxides | 2023 |
Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis.
Topics: Animals; Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Movement; Female; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Sulfides; Wound Healing | 2020 |
[Effect of Cell Autophagy on the Apoptosis of Hepatocellular Carcinoma Cells Induced by Arsenic Trioxide].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; Microtubule-Associated Proteins | 2017 |
A carcinogenicity study of diphenylarsinic acid in F344 rats in drinking water for 104 weeks.
Topics: Administration, Oral; Animals; Arsenicals; Body Weight; Chemical Warfare Agents; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Male; Rats, Inbred F344; Survival Rate; Time Factors; Water; Water Pollutants, Chemical | 2017 |
Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
Topics: Apoptosis; Arsenicals; Carcinoma, Hepatocellular; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mitochondria; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured | 2017 |
Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Mice, Nude; Neovascularization, Pathologic; Oxides; Xenograft Model Antitumor Assays | 2018 |
γ-Glutamylcysteine synthetase (γ-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Catalysis; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Glutamate-Cysteine Ligase; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Oxides; Radiation Tolerance; Reactive Oxygen Species | 2018 |
Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Oxides; Receptors, Notch | 2018 |
Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flavonoids; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Oxides; Reactive Oxygen Species; Transplantation, Heterologous | 2014 |
Diphenylarsinic acid, a chemical warfare-related neurotoxicant, promotes liver carcinogenesis via activation of aryl hydrocarbon receptor signaling and consequent induction of oxidative DNA damage in rats.
Topics: Animals; Apoptosis; Arsenicals; Aryl Hydrocarbon Hydroxylases; bcl-2-Associated X Protein; Body Weight; Carcinogenesis; Carcinogens; Chemical Warfare Agents; Cytochrome P-450 CYP1B1; Diethylnitrosamine; DNA Damage; Japan; Liver; Liver Neoplasms; Male; Neurotoxins; Organ Size; Oxidative Stress; Rats; Rats, Inbred F344; Receptors, Aryl Hydrocarbon; Signal Transduction; Transcriptional Activation | 2013 |
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
Topics: AC133 Antigen; Animals; Antigens, CD; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Glycoproteins; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oxides; Peptides; Random Allocation; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2014 |
Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
Topics: Arsenic Trioxide; Arsenicals; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Oxides; Signal Transduction | 2014 |
Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Embolization, Therapeutic; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Oxides; Rats; Rats, Inbred BUF; Twist-Related Protein 1 | 2014 |
Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles, an antibody conjugate with potent and selective anti-hepatocellular carcinoma activity.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Immunohistochemistry; Leukocyte Count; Liver Neoplasms; Male; Mice, Nude; Microvessels; Nanoparticles; Oxides; Platelet Count; Single-Chain Antibodies; Tissue Distribution; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Nuclear Proteins; Oxides; Piperazines; Signal Transduction; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2014 |
Exposure of hepatocellular carcinoma cells to low-level As₂O₃ causes an extra toxicity pathway via L1 retrotransposition induction.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coloring Agents; Deoxyribonuclease I; DNA; Flow Cytometry; Green Fluorescent Proteins; Humans; Indicators and Reagents; Liver Neoplasms; Liver Neoplasms, Experimental; Microscopy, Fluorescence; Oxides; Plasmids; Real-Time Polymerase Chain Reaction; Retroelements; Tetrazolium Salts; Thiazoles; Transfection | 2014 |
Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Delivery Systems; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Microvessels; Nanoparticles; Neovascularization, Pathologic; Oxides; Single-Chain Antibodies; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Tretinoin | 2014 |
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; NF-kappa B; Oxides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2014 |
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Topics: 3' Untranslated Regions; AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Oxides; Peptides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2015 |
[The apoptotic mechanism of hepatocellular carcinoma cell line (HepG2) induced by arsenic trioxide].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Glutamate-Cysteine Ligase; Glutathione; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Reactive Oxygen Species | 2014 |
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Niacinamide; Oxides; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib | 2015 |
Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2015 |
PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cyclin B1; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Naphthalimides; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Up-Regulation | 2015 |
[4-amino-1,8-naphthalimide on the Sensitive effect of arsenic trioxide in hepatocellular carcinoma cells].
Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Survival; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Liver Neoplasms; Naphthalimides; Oxides; Quinolones | 2015 |
The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
Topics: 1-Naphthylamine; Acetylcysteine; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Inactivation, Metabolic; Liver Neoplasms; Naphthalimides; NF-kappa B; Oxidative Stress; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Reactive Oxygen Species | 2015 |
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic.
Topics: Amino Acid Motifs; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinogenesis; Cell Line; Cell Transformation, Neoplastic; Computational Biology; DNA Methylation; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Liver; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Oxides; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Transcription Factors; Transcriptional Activation; Wnt Proteins | 2015 |
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Topics: Adult; Aged; Aldehyde Dehydrogenase; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2015 |
Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxides; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A | 2016 |
A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Female; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Nanoparticles; Oxides; Porosity; Silicon Dioxide; Surface Properties; Transplantation, Heterologous | 2016 |
[Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib | 2015 |
Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Dextrans; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Kinetics; Liver Neoplasms; Mice; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Invasiveness; Neoplasm Transplantation; Oxides; Phosphates; Rats; Spectroscopy, Fourier Transform Infrared; Thermodynamics | 2016 |
[The Experiment Study and Mechanism of Aspirin Enhances Cellular Sensitivity of Hepatocellular Carcinoma Cell Line to Arsenic Trioxide].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Heme Oxygenase-1; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxides; Reactive Oxygen Species | 2016 |
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; DNA Damage; Drug Synergism; Endoplasmic Reticulum Stress; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Naphthoquinones; Oxides; Xenograft Model Antitumor Assays | 2016 |
microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice, Nude; MicroRNAs; Oxides | 2016 |
Arsenic trioxide is an immune adjuvant in liver cancer treatment.
Topics: Adjuvants, Immunologic; Animals; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytokine-Induced Killer Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Mice; Oxides; Real-Time Polymerase Chain Reaction; T-Lymphocytes; Xenograft Model Antitumor Assays | 2017 |
Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS.
Topics: Acidithiobacillus; Antineoplastic Agents; Apoptosis; Arsenicals; Biodegradation, Environmental; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Reactive Oxygen Species; Sulfides | 2017 |
RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms; MCF-7 Cells; Mice; Nanoparticles; Oligopeptides; Oxides; Silicon Dioxide | 2017 |
Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Phenanthrenes; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
Topics: Androstadienes; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Wortmannin | 2009 |
Possible roles of a tumor suppressor gene PIG11 in hepatocarcinogenesis and As2O3-induced apoptosis in liver cancer cells.
Topics: Adult; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Child; Cycloheximide; Dactinomycin; Down-Regulation; Female; Gene Expression; Gene Knockdown Techniques; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Oxides; Protein Synthesis Inhibitors | 2009 |
Structure-effect relationship in the down-regulation of glutaminase in cultured human cells by phenylarsenic compounds.
Topics: Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Glutaminase; Hepatocytes; Humans; Liver Neoplasms; Molecular Structure; Time Factors | 2009 |
The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxides; Phosphorylation; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53; Up-Regulation; Verapamil | 2009 |
Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biocompatible Materials; Cell Line, Tumor; Female; Ferric Compounds; Humans; Hyperthermia, Induced; Liver Neoplasms; Magnetics; Male; Materials Testing; Medicine, Chinese Traditional; Mice; Mice, Nude; Nanospheres; Oxides; Random Allocation; Swine; Transplantation, Heterologous | 2009 |
Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice; NM23 Nucleoside Diphosphate Kinases; Oxides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Genistein; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Oxides; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2010 |
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Synergism; Genistein; Hep G2 Cells; Humans; Liver Neoplasms; Mice; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2011 |
microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Oxides; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Reverse Transcriptase Polymerase Chain Reaction; Transfection | 2011 |
Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Liver Neoplasms; Membrane Potential, Mitochondrial; Nitric Oxide; Oxides; Oxygen; Reactive Oxygen Species; Tumor Cells, Cultured | 2011 |
Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Humans; Inhibitor of Apoptosis Proteins; Interferon Inducers; Liver Neoplasms; Mitochondria; Oxides; Poly I-C; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Survivin; Toll-Like Receptor 3 | 2011 |
[Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
Topics: Amphibian Venoms; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; Phytotherapy; Xenograft Model Antitumor Assays | 2011 |
Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.
Topics: Angiography; Animals; Arsenic Trioxide; Arsenicals; Embolization, Therapeutic; Hyperthermia, Induced; Immunohistochemistry; Liver; Liver Function Tests; Liver Neoplasms; Male; Microvessels; Nanoparticles; Necrosis; Oxides; Platelet Endothelial Cell Adhesion Molecule-1; Rabbits; Survival Analysis; Temperature; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Growth Processes; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxides; Telomerase; Xenograft Model Antitumor Assays; Zidovudine | 2011 |
Pharmacokinetics of arsenic trioxide (As₂O₃) in Chinese primary hepatocarcinoma patients.
Topics: Area Under Curve; Arsenic Trioxide; Arsenicals; Asian People; Carcinoma, Hepatocellular; Female; Half-Life; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides | 2011 |
Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Topics: 3' Untranslated Regions; Antigens, Surface; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; ELAV Proteins; ELAV-Like Protein 1; ErbB Receptors; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Homeodomain Proteins; Humans; Liver Neoplasms; Models, Biological; Oxides; Phosphatidylinositol 3-Kinases; Repressor Proteins; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta | 2011 |
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Capecitabine; Carcinoma, Hepatocellular; Cell Line; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Glycoproteins; Hep G2 Cells; Humans; Immunohistochemistry; Interferon-alpha; Liver Neoplasms; Oxides; Peptides; Rhodamine 123; Thy-1 Antigens | 2011 |
Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Ceramides; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Microscopy, Fluorescence; Neoplasm Invasiveness; Oxides; Sphingomyelin Phosphodiesterase | 2012 |
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diterpenes, Kaurane; Drug Synergism; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; X-Linked Inhibitor of Apoptosis Protein | 2012 |
Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.
Topics: Antineoplastic Agents; Arsenicals; Cell Line; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; DNA Damage; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Models, Molecular; Neoplastic Stem Cells; Organoplatinum Compounds; Palladium | 2012 |
Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.
Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Animals; Arsenic; Arsenicals; Carcinogens; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Lung Neoplasms; Male; Maternal Exposure; Mice; Neoplasms; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Testicular Neoplasms; Uterine Neoplasms | 2012 |
Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin B; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction | 2012 |
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
Topics: Adult; AMP-Activated Protein Kinases; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Thymidylate Synthase; Time Factors | 2012 |
[Inhibitory effect of arsenic trioxide on invasion in human hepatocellular carcinoma SMMC-7721 cells and its mechanism].
Topics: Arsenic Trioxide; Arsenicals; Basigin; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Oxides | 2012 |
[Comparison of antitumor efficacy between arsacetyl and arsenic trioxide in vitro].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Fragmentation; Drug Screening Assays, Antitumor; Endothelium, Vascular; Flow Cytometry; G1 Phase; Humans; Inhibitory Concentration 50; Liver Neoplasms; Oxides; Resting Phase, Cell Cycle; Tumor Cells, Cultured | 2002 |
Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 CYP1A1; Dioxins; Drug Synergism; Enzyme Induction; Genes, Reporter; Hepatocytes; Humans; Immunoblotting; In Vitro Techniques; Liver Neoplasms; Mitochondrial Proteins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Oxides; Polycyclic Aromatic Hydrocarbons; Protein Processing, Post-Translational; Reactive Oxygen Species; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; Flow Cytometry; Growth Inhibitors; Humans; Liver Neoplasms; Oxides; Tumor Cells, Cultured | 2003 |
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured | 2003 |
Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Female; Liver Neoplasms; Male; Microscopy, Electron; Oxides; Rats; Rats, Wistar; Tumor Cells, Cultured | 2003 |
[Mechanism of arsenic trioxide-induced apoptosis in hepatic blastoma cells HepG2].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2003 |
A case of cirrhosis and primary carcinoma of the liver in chronic industrial arsenical intoxication.
Topics: Arsenicals; Carcinoma; Humans; Liver Cirrhosis; Liver Neoplasms; Medical Records | 1959 |
Antitumor effect of arsenic trioxide in murine xenograft model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain; Carcinoma, Hepatocellular; Humans; In Situ Nick-End Labeling; Injections, Intravenous; Kidney; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Spectrometry, X-Ray Emission; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2).
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Cloning, Molecular; Gene Expression Regulation, Neoplastic; Genes, Reporter; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Metallothionein; Oxides; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
[Application of arsenic trioxide in comprehensive therapy of liver carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Oxides | 2003 |
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model.
Topics: Adrenergic Agonists; Anesthetics, Inhalation; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Catheter Ablation; Disease Models, Animal; Epinephrine; Halothane; Kidney; Kidney Neoplasms; Laser-Doppler Flowmetry; Liver; Liver Neoplasms; Oxides; Rabbits; Regional Blood Flow | 2004 |
[Study on effect of arsenic trioxide on adhesion and invasion of human hepatocarcinoma cells in vitro].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Liver Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Invasiveness; Oxides | 2004 |
[The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Middle Aged; Oxides | 2005 |
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; B7 Antigens; B7-1 Antigen; Carcinoma, Hepatocellular; Combined Modality Therapy; Gene Transfer Techniques; Humans; Immunotherapy; Interferon-gamma; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Receptors, Immunologic; T-Lymphocytes, Cytotoxic | 2006 |
Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Neoplasm; Genes, p16; Glutathione S-Transferase pi; Hepatocytes; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; RNA, Messenger; Tumor Suppressor Proteins | 2006 |
Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Free Radical Scavengers; Humans; Liver Neoplasms; Oxidative Stress; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2006 |
Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dithiothreitol; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Environmental Pollutants; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxides; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2008 |
[Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; COP9 Signalosome Complex; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Oxides; Peptide Hydrolases | 2007 |
Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
Topics: Animals; Arsenic Trioxide; Arsenicals; Binding Sites; Carcinoma, Hepatocellular; Caspases; Cell Death; Cell Line, Tumor; Cytochromes c; Dinitrochlorobenzene; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Liver Neoplasms; Mice; Mitochondria; Mitochondrial Swelling; Mutant Proteins; NADP; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Recombinant Proteins; RNA Interference; Thioredoxins | 2008 |
[Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Oxides; Phenylurea Compounds; Pyridines; Sorafenib | 2008 |
Hepatic angiosarcoma associated with short-term arsenic ingestion.
Topics: Arsenic; Arsenicals; Carcinoma, Basal Cell; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Skin Neoplasms; Time Factors | 1982 |
Influence of vinyl chloride monomer (VCM) and As2O3 on rat liver cell proliferation after partial hepatectomy.
Topics: Alkaline Phosphatase; Animals; Arsenic; Arsenic Trioxide; Arsenicals; Dose-Response Relationship, Drug; Hepatectomy; Liver; Liver Neoplasms; Liver Regeneration; Male; Mitosis; Oxides; Rats; Vinyl Chloride; Vinyl Compounds | 1980 |
Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
Topics: Antineoplastic Agents; Arsenicals; Blotting, Northern; Carcinoma, Squamous Cell; Carrier Proteins; Cell Membrane; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Antibody Technique, Indirect; Folate Receptors, GPI-Anchored; Humans; Liver Neoplasms; Membrane Proteins; Metals; Methotrexate; Neoplasm Proteins; Receptors, Cell Surface; Tumor Cells, Cultured | 1998 |
[An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; fas Receptor; Genes, bcl-2; Humans; In Situ Nick-End Labeling; Liver Neoplasms; Oxides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; S Phase; Tumor Cells, Cultured | 2000 |
Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2).
Topics: Arsenic Trioxide; Arsenicals; Atrazine; Cell Line, Transformed; Cell Survival; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Gene Expression; Gene Expression Profiling; Hepatocytes; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Metallothionein; Oxides; Proto-Oncogene Proteins c-fos | 2001 |
[Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer].
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Gallbladder Neoplasms; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxides; Quality of Life; Treatment Outcome | 2001 |
Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Nucleus; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Kinetics; Liver Neoplasms; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured | 2002 |
Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Cycle; Cell Division; Enzyme Activation; Humans; Liver Neoplasms; Mitochondria; Oxides; Tumor Cells, Cultured | 2002 |
Vinyl chloride-associated liver disease.
Topics: Adult; Animals; Arsenicals; Chemical and Drug Induced Liver Injury; Epidemiologic Methods; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Occupational Diseases; Polymers; Radionuclide Imaging; Rats; Thorium Dioxide; Time Factors; Vinyl Chloride; Vinyl Compounds | 1976 |
Liver biopsy in psoriatics previously treated with potassium arsenite. A controlled study.
Topics: Arsenicals; Biopsy; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Microscopy, Electron; Psoriasis | 1974 |
Inhibition of cellular adhesiveness by sulfhydryl blocking agents.
Topics: Alkylating Agents; Animals; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line; Cells, Cultured; Culture Media; Culture Techniques; Dithiothreitol; Liver Neoplasms; Mercuribenzoates; Polystyrenes; Rats; Sulfhydryl Reagents; Time Factors | 1971 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium | 1974 |
Significance of Inflammation and Apoptosis in Hepatocellular Death in Rat, Co-treated with Arsenic and Fluoride.
Topics: Animals; Apoptosis; Arsenic; Body Weight; Carcinoma, Hepatocellular; Caspase 9; Female; Fluorides; Inflammation; Liver Neoplasms; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
Topics: Animals; Antineoplastic Agents; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Liver Neoplasms; Metal-Organic Frameworks; Mice; Nanoparticles; Radiofrequency Ablation; Tissue Distribution | 2022 |
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
Topics: Arsenic; Carcinoma, Hepatocellular; Heme Oxygenase-1; Humans; Liver Neoplasms; Oxidative Stress; Ubiquitin-Specific Peptidase 7 | 2022 |
Identification of therapeutic miRNAs from the arsenic induced gene expression profile of hepatocellular carcinoma.
Topics: Arsenic; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Transcriptome | 2023 |
Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
Topics: Arsenic; Arsenites; beta-Galactosidase; Cellular Senescence; Culture Media, Conditioned; DNA; Hepatic Stellate Cells; Humans; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Phenotype; RNA, Messenger; Senescence-Associated Secretory Phenotype | 2022 |
Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Biomimetics; Carcinoma, Hepatocellular; Cell Line, Tumor; Ferroptosis; Liver Neoplasms; Magnetic Iron Oxide Nanoparticles; Mice | 2023 |
Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells.
Topics: Arsenic; Arsenites; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression; Humans; Liver Neoplasms | 2023 |
Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study.
Topics: Adult; Arsenic; Carcinoma, Hepatocellular; Ethnicity; Female; Humans; Incidence; Liver Neoplasms; Male; Receptors, Antigen, T-Cell; Sex Characteristics; Texas; Young Adult | 2024 |
Effects of Selenium on Arsenic-Induced Liver Lesions in Broilers.
Topics: Animals; Arsenic; Chickens; Liver; Liver Neoplasms; Male; Selenium | 2021 |
Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic; Carcinoma, Hepatocellular; Cell Cycle; Drug Delivery Systems; Drug Synergism; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2021 |
Comparison of cytotoxicity and membrane efflux pump inhibition in HepG2 cells induced by single-walled carbon nanotubes with different length and functional groups.
Topics: Arsenic; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Fluidity; Nanotubes, Carbon; Oxidative Stress; Reactive Oxygen Species | 2019 |
Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.
Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Proliferation; Cyclins; Disease Progression; E2F1 Transcription Factor; Flow Cytometry; Hepatocytes; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Protein Kinases; Sequence Analysis, RNA | 2017 |
Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile.
Topics: Adolescent; Arsenic; Child; Child, Preschool; Chile; Female; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Poisson Distribution; Water Supply; Young Adult | 2008 |
Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.
Topics: Animals; Arsenic; Collagen; DNA Primers; Female; Gene Expression Profiling; Gene Expression Regulation; Liver; Liver Neoplasms; Mice; Oligonucleotide Array Sequence Analysis; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
[Effect of selenium and arsenic on oxidative stress, DNA oxidative damage and repair in HepG2 cells].
Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Carcinoma, Hepatocellular; Deoxyguanosine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Malondialdehyde; Oxidative Stress; Selenium | 2008 |
Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Embolization, Therapeutic; Emulsions; Hemostatics; Humans; Iodized Oil; Liver; Liver Neoplasms; Rabbits; Treatment Outcome | 2009 |
Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells.
Topics: Amino Acid Sequence; Arsenic; Arsenites; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Glutathione; Humans; Liver Neoplasms; Molecular Sequence Data; Neoplasm Proteins | 2010 |
Comparative study of liver cancer patients in arsenic exposed and non-exposed areas of Pakistan.
Topics: Adult; Aged; Arsenic; Calibration; Drinking Water; Environmental Exposure; Hair; Humans; Indicators and Reagents; Liver Neoplasms; Male; Maximum Allowable Concentration; Microwaves; Middle Aged; Pakistan; Spectrophotometry, Atomic; Water Pollutants, Chemical; Water Supply | 2011 |
Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice.
Topics: Adrenal Gland Neoplasms; Animals; Arsenic; Cacodylic Acid; Female; Histocytochemistry; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Survival Analysis | 2012 |
Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
Topics: Adult; Aged; Arsenic; Biomarkers, Tumor; Carcinogens; Case-Control Studies; Environmental Exposure; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Female; Humans; Liver Neoplasms; Male; Middle Aged; Risk Factors; Taiwan | 2012 |
Investigation of essential trace and toxic elements in biological samples (blood, serum and scalp hair) of liver cirrhotic/cancer female patients before and after mineral supplementation.
Topics: Adult; Arsenic; Case-Control Studies; Dietary Supplements; Female; Hair; Humans; Lead; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Nickel; Scalp; Selenium; Trace Elements; Young Adult; Zinc | 2012 |
Arsenic levels in drinking water and mortality of liver cancer in Taiwan.
Topics: Adolescent; Adult; Aged; Arsenic; Child; Child, Preschool; Cities; Dose-Response Relationship, Drug; Drinking Water; Environmental Exposure; Environmental Monitoring; Female; Humans; Infant; Infant, Newborn; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Registries; Regression Analysis; Risk Assessment; Software; Taiwan; Water Pollutants, Chemical; Young Adult | 2013 |
Pathology related to chronic arsenic exposure.
Topics: Adolescent; Adult; Aged; Arsenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Environmental Exposure; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Diseases; Water Supply | 2002 |
[Arsenic, liver and tumors; hemangioendothelioma].
Topics: Arsenic; Arsenic Poisoning; Hemangioendothelioma; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms | 1957 |
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
Topics: Animals; Arsenic; Carcinogens; Carcinoma, Hepatocellular; Drinking; Female; Gene Expression; Gene Expression Profiling; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Polymerase Chain Reaction; Water; Water Pollutants, Chemical | 2004 |
Cancer burden from arsenic in drinking water in Bangladesh.
Topics: Age Factors; Arsenic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Population Surveillance; Prospective Studies; Risk Factors; Sex Factors; Taiwan; Urinary Bladder Neoplasms; Water Pollutants, Chemical | 2004 |
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.
Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured | 2004 |
Simultaneous determination of arsenic and selenium in biological samples by HG-AFS.
Topics: Animals; Arsenic; Borohydrides; Cattle; Liver Neoplasms; Rabbits; Selenium; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Swine | 2005 |
Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.
Topics: Administration, Topical; Animals; Arsenic; Female; Gene Expression Profiling; Gene Expression Regulation; Liver; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Tetradecanoylphorbol Acetate | 2006 |
Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure.
Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Pregnancy; Prenatal Exposure Delayed Effects; Toxicogenetics | 2006 |
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.
Topics: Animals; Arsenic; Diethylstilbestrol; Drug Synergism; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Female; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Pregnancy; Prenatal Exposure Delayed Effects; Selective Estrogen Receptor Modulators; Tamoxifen; Urinary Bladder Neoplasms | 2006 |
Phenotypic anchoring of arsenic and cadmium toxicity in three hepatic-related cell systems reveals compound- and cell-specific selective up-regulation of stress protein expression: implications for fingerprint profiling of cytotoxicity.
Topics: Animals; Arsenic; Cadmium; Cell Survival; Cells, Cultured; DNA Fingerprinting; Heat-Shock Proteins; Hepatocytes; Humans; Liver Neoplasms; Male; Phenotype; Rats; Rats, Wistar; Up-Regulation | 2006 |
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
Topics: Animals; Arsenic; Arsenites; Azacitidine; Blotting, Western; Carcinogens; Cell Cycle; Cell Line; Cell Transformation, Neoplastic; Dealkylation; Decitabine; DNA, Neoplasm; Gene Expression; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Growth; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stress, Physiological | 2006 |
Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin.
Topics: Animals; Arsenic; Benzothiazoles; Cadmium; Cell Line, Tumor; Cells, Cultured; Cytoprotection; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Regulation; Hepatoblastoma; Hepatocytes; Humans; Lethal Dose 50; Liver Neoplasms; Male; Neoplasm Proteins; Rats; Rats, Wistar; Toluene; Tumor Suppressor Protein p53 | 2007 |
[The determination of the level of arsenic in human liver tissue under physiological and pathological conditions].
Topics: Arsenic; Colorimetry; Fatty Liver; Humans; In Vitro Techniques; Liver; Liver Cirrhosis; Liver Neoplasms | 1967 |
Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler's solution.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Arsenic; Arsenites; Dermatitis Herpetiformis; Hemangiosarcoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Potassium; Potassium Compounds; Smoking | 1984 |
New approaches to the neutron activation analysis in biomedical sciences.
Topics: Activation Analysis; Animals; Arsenic; Bone and Bones; Copper; Gold; Gold Colloid, Radioactive; Humans; Kidney; Liver; Liver Neoplasms; Mercury; Muscles; Neutron Activation Analysis; Phosphorus; Potassium; Rats; Sodium | 1980 |
[Angiosarcoma of the liver after short-term arsenic therapy].
Topics: Arsenic; Dose-Response Relationship, Drug; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Psoriasis | 1984 |
Angiosarcoma of the liver: a growing problem?
Topics: Animals; Arsenic; Hemangiosarcoma; Humans; Liver Neoplasms; Neoplasms, Radiation-Induced; Occupational Diseases; Polyvinyl Chloride; Rats; Thorium Dioxide; United Kingdom | 1981 |
The consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomical investigations of post-mortem examinations performed between 1960 and 1977.
Topics: Arsenic; Arsenic Poisoning; Autopsy; Data Collection; Germany, West; Humans; Insecticides; Liver Cirrhosis; Liver Neoplasms; Lung Neoplasms; Neoplasms, Multiple Primary; Occupational Diseases; Skin Neoplasms; Wine | 1983 |
Arsenic-related hepatic angiosarcoma.
Topics: Adult; Arsenic; Arsenites; Asthma; Environmental Exposure; Female; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Potassium; Potassium Compounds; United States; Vinyl Chloride | 1981 |
Epidemiology of angiosarcoma of liver in New York State.
Topics: Adolescent; Adult; Aged; Arsenic; Environmental Exposure; Female; Hemangiosarcoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Middle Aged; New York; Registries; Thorium Dioxide; Vinyl Chloride | 1981 |
Review of four cases of childhood hepatic angiosarcoma--elevated environmental arsenic exposure in one case.
Topics: Arsenic; Carcinogens, Environmental; Child, Preschool; Environmental Exposure; Female; Hemangioendothelioma; Hemangiosarcoma; Humans; Infant; Liver Neoplasms; Risk | 1981 |
Tumors in patients with angiosarcoma of the liver.
Topics: Adult; Aged; Arsenic; Female; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Thorium Dioxide; Vinyl Chloride | 1981 |
Arsenic dose in patients with cutaneous carcinomata and hepatic hemangio-endothelioma after environmental and occupational exposure.
Topics: Adult; Arsenic; Female; Hemangioendothelioma; Humans; Liver Neoplasms; Male; Middle Aged; Occupational Diseases; Regression Analysis; Skin Neoplasms; Water Pollutants; Water Pollutants, Chemical; Water Supply | 1981 |
Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan.
Topics: Adult; Arsenic; Carcinogens; Dose-Response Relationship, Drug; Environmental Exposure; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms; Risk Assessment; Taiwan; Urinary Bladder Neoplasms; Water Pollution; Water Supply | 1995 |
[A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia].
Topics: Arsenic; China; Humans; Incidence; Liver Neoplasms; Longitudinal Studies; Lung Neoplasms; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms; Water Pollutants, Chemical; Water Supply | 1995 |
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina.
Topics: Argentina; Arsenic; Environmental Exposure; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Water Supply | 1998 |
Risk of internal cancers from arsenic in drinking water.
Topics: Adult; Aged; Aged, 80 and over; Arsenic; Diet; Female; Humans; Incidence; Life Expectancy; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Public Health; Risk Assessment; Urinary Bladder Neoplasms; Water Supply | 2000 |
Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.
Topics: Arsenic; Arsenic Poisoning; Biopsy, Needle; Carcinogens, Environmental; Carcinoma, Hepatocellular; China; DNA, Complementary; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Necrosis; Oligonucleotide Array Sequence Analysis; RNA | 2001 |
A touch of poison.
Topics: Argentina; Arsenic; Chile; Humans; Liver Neoplasms; Lung Neoplasms; Mining; Skin Neoplasms; Taiwan; United States; United States Environmental Protection Agency; Urinary Bladder Neoplasms; Water Pollutants, Chemical; Water Supply | 2001 |
[Liver tumors caused by environmental factors].
Topics: Anabolic Agents; Animals; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Environmental Exposure; Environmental Health; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasms, Experimental; Occupational Diseases; Precancerous Conditions; Rodentia; Thorium Dioxide; Vinyl Chloride | 1977 |
Liver disease associated with chronic arsenic ingestion.
Topics: Arsenic; Carcinoma, Basal Cell; Carcinoma, Hepatocellular; Humans; Keratosis; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Neoplasms | 1979 |
Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.
Topics: Adolescent; Adult; Aged; Arsenic; Child, Preschool; Female; Hemangiosarcoma; Humans; Hyperplasia; Liver; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Thorium Dioxide; Vinyl Chloride; Vinyl Compounds | 1978 |
Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite).
Topics: Adult; Arsenic; Arsenites; Cobalt Radioisotopes; Hemangiosarcoma; Humans; Liver; Liver Neoplasms; Male; Potassium; Potassium Compounds; Psoriasis | 1975 |
Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water.
Topics: Adult; Aged; Arsenic; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Organ Specificity; Risk Factors; Sex Factors; Taiwan; Urinary Bladder Neoplasms; Water Supply | 1992 |
Activation of heme oxygenase and heat shock protein 70 genes by stress in human hepatoma cells.
Topics: Arsenic; Arsenites; Cadmium; Cadmium Chloride; Carcinoma, Hepatocellular; Cell Line; Gene Expression Regulation; Heat-Shock Proteins; Heme; Heme Oxygenase (Decyclizing); Hot Temperature; Humans; Iodoacetamide; Kinetics; Liver Neoplasms; Mixed Function Oxygenases; RNA, Messenger; Sodium Compounds; Transcription, Genetic; Tumor Cells, Cultured | 1990 |
Arsenic and non-cirrhotic portal hypertension. A report of eight cases.
Topics: Adult; Arsenic; Biopsy; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Psoriasis; Skin Neoplasms | 1990 |
[Hepato-splenic hemangiosarcoma: presentation of a clinical case].
Topics: Aged; Agricultural Workers' Diseases; Arsenic; Carcinoma, Hepatocellular; Colonic Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Mesentery; Neoplasms, Multiple Primary; Omentum; Peritoneal Neoplasms; Splenic Neoplasms; Uruguay | 1989 |
[Angiosarcoma of the liver following brief arsenic therapy].
Topics: Arsenic; Hemangiosarcoma; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Psoriasis | 1985 |
ATP level and control of glycolysis in Novikoff ascites-hepatoma cells.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Arsenic; Ascites; Carcinoma, Hepatocellular; Dinitrophenols; Glucose; Glycolysis; Hexosephosphates; Iodoacetates; Lactates; Liver Neoplasms; Neoplasms, Experimental; Rats; Stimulation, Chemical | 1969 |
Effect of feeding amino azo dyes on mitochondrial swelling and contraction. Kinetic evidence for deletion of membrane regulatory sites.
Topics: Adenosine Triphosphate; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Membrane; Chloromercuribenzoates; Kinetics; Liver Neoplasms; Male; Methods; Mitochondria, Liver; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Phlorhizin; Phosphates; Potassium Chloride; Proteins; Rats; Saponins; Sucrose; Thyroxine; Time Factors | 1969 |
Studies on cell adhesion. II. Adhesion of cells to surfaces of diverse chemical composition and inhibition of adhesion by sulfhydryl binding reagents.
Topics: Agar; Alloys; Aluminum; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Division; Cell Line; Densitometry; Ethylmaleimide; Glass; Iodoacetates; Kinetics; Liver Neoplasms; Mercuribenzoates; Mercury; Polyethylenes; Polymers; Polytetrafluoroethylene; Rats; Silicones | 1972 |
The determination of arylsulfatases in biological fluids.
Topics: 1-Propanol; Alcoholism; Arsenic; Coumarins; Drug Stability; Fluorometry; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Neoplasms; Methods; Pancreatitis; Poisoning; Saliva; Sulfatases | 1970 |
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution.
Topics: Arsenic; Carcinogens; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Psoriasis | 1968 |
Life term studies on the effect of trace elements on spontaneous tumors in mice and rats.
Topics: Adrenal Gland Neoplasms; Animals; Antimony; Arsenic; Cadmium; Chromates; Diet; Female; Fluorine; Germanium; Lead; Liver Neoplasms; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Niobium; Rats; Time Factors; Tin; Trace Elements; Zirconium | 1969 |